Nalmefene

This classification denotes an opiate antagonist with the molecular formula C21H25NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TOV02TDP9I, chemically known as morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, (5.alpha.)- but generally known as nalmefene, which bears US NIH Compound Identifier 4422. European Medicines Agency schedules Nalmefene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09139MIG. The term NALMEFENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). NALMEFENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nalmefene under HS 29391900 and SITC 54141. As of Q4 2014, NALMEFENE remains the US FDA Preferred Term for this commodity. Nalmefene bears US NLM identifiers UMLS ID C0068377 and NCI Concept Code C61855. SMILES: O1C2C34C(O)(C(N(CC3)CC3CC3)CC3C4C1C(O)CC3)CCC2=C.